A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial NCT02992288 · COMPLETED
Trial details
- NCT number
- NCT02992288
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2018-03-28
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.